Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
"The drug of intravenous patient-controlled analgesia" is a non-specific placeholder term used in clinical trial registries (such as NCT04295109) to refer to the analgesic agents administered via an intravenous patient-controlled analgesia (IV-PCA) system. In the context of postoperative pain management, particularly following surgeries like laparoscopic hysterectomy, various opioid receptor agonists—such as fentanyl, oxycodone, and butorphanol—are utilized within this modality to provide patient-controlled pain relief while their comparative effects on postoperative gastrointestinal recovery and side effects are evaluated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on the drug of intravenous patient-controlled analgesia.